Клинический разбор в общей медицине

Сахарный диабет (СД) – хроническое заболевание, связанное с развитием микро- и макрососудистых осложнений, предотвращение которых – важная задача современной медицины. Современные средства управления диабетом предполагают активную роль пациента. Самоконтроль гликемии является основой эффективности проводимой сахароснижающей терапии и профилактики гипогликемии, повышения приверженности пациентов к лечению. Важность самоконтроля еще более возросла во время пандемии COVID-19, поскольку надлежащий гликемический контроль может снизить риск заражения COVID-19 и тяжесть заболевания у пациентов с СД. Обсуждается рекомендуемая частота самоконтроля гликемии при СД. Для измерения сахара крови доступны разнообразные глюкометры. Важными критериями при выборе глюкометра являются соответствие стандартам точности, простота и удобство использования для пациентов.

1.   IDF Diabetes Atlas. 9th edition, 2019. URL: https://diabetesatlas.org/en/resources

2.   Xu L, Mao Y, Chen G. Risk factors for 2019 novel coronavirus disease (COVID-19) patients progressing to critical illness: A systematic review and meta-analysis. Aging (Albany NY) 2020; 12: 12410–21. DOI: 10.18632/aging.103383

3.   Шестакова М.В. Сахарный диабет в условиях вирусной пандемии COVID-19. Сахарный диабет. 2020; 23 (2): 132–9.

      [Shestakova M.V. Sakharnyi diabet v usloviiakh virusnoi pandemii COVID-19. Sakharnyi diabet. 2020; 23 (2): 132–9 (in Russian).]

4.   Rawshani A, Kjölhede EA, Rawshani A et al. Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden. The Lancet Regional Health – EuropeA nationwide retrospective cohort study. 2001; 4. www.sciencedirect.com/science/article/pii/S266677622100082X?via%3Dihub

5.   Zaki N, Alashwal H, Ibrahim S. Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review. Diabetes Metab Syndr Clin Res Rev 2020; 14: 1133–42.

6.   Glycemic Targets: Standards of Medical Care in Diabetes—2021. American Diabetes Association Diabetes Care 2021; 44 (Suppl. 1): S73-S84. DOI: 10.2337/dc21-S006

7.   Алгоритмы специализированной медицинской помощи больных сахарным диабетом. Под редакцией И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 10-й выпуск. М., 2021.

      [Standards of specialized diabetes care. Edited by I.I. Dedov, M.V. Shestakova, A.Yu. Mayorov. 10th Edition. Moscow, 2021 (in Russian).]

8.   Davies MJ, D’Alessio DA, Fradkin J et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2018; 41 (12): 2669–2701. DOI: 10.2337/dci18-0033

9.   International Diabetes Federation. Guideline on self-monitoring of blood glucose in non-insulin treated type 2 diabetes. Available from: https://www.idf.org/e-library/guidelines/85-self-monitoring-of-blood-glucose-in-non-insulin-treated-type-2-diabetes.html. Accessed 2020.

10. Майоров А.Ю., Мельникова О.Г., Филиппов Ю.И. Вопросы самоконтроля гликемии в практике лечения сахарного диабета. Справочник поликлинического врача. 2012; 12: 32–6.

      [Maiorov A.Iu., Mel'nikova O.G., Filippov Iu.I. Voprosy samokontrolia glikemii v praktike lecheniia sakharnogo diabeta. Spravochnik poliklinicheskogo vracha. 2012; 12: 32–6 (in Russian).]

11. Machry RV, Rados DV, Gregório GR & Rodrigues TC. Self-monitoring blood glucose improves glycemic control in type 2 diabetes without intensive treatment: a systematic review and meta-analysis. Diabetes Res Clin Pract 2018; 142: 173–87.

12. Hon-Ke Sia, Chew-Teng Kor, Shih-Te Tu. Self-monitoring of blood glucose in association with glycemic control in newly diagnosed non-insulin-treated diabetes patients: a retrospective cohort study. Sci Rep 2021; 11: 1176. www.nature.com/articles/s41598-021-81024-x

13. Егшатян Л.В., Бирюкова Е.В. Влияния железодефицитной анемии на значения гликированного гемоглобина. Лечение и профилактика. 2015; 2 (14): 60–4.

      [Egshatian L.V., Biriukova E.V. Vliianiia zhelezodefitsitnoi anemii na znacheniia glikirovannogo gemoglobina. Lechenie i profilaktika. 2015; 2 (14): 60–4 (in Russian).]

14. Bloomgarden Z, Handelsman Y. How does CKD affect HbA1c? J Diabetes 2018; 10 (4): 270. DOI: 10.1111/1753-0407.12624

15. Hanefeld M, Frier BM, Pistrosch F. Hypoglycemia and Cardiovascular Risk: Is There a Major Link? Diabetes Care 2016; 39 (Suppl. 2): S205–S209.

16. Chow E, Bernjak A, Williams S et al. Risk of cardiac arrhythmias during hypoglycemia in young people with type 1 diabetes. Diabetes Care 2017; 40 (5): 655–62. DOI: 10.2337/dc16-2177

17. Cox DJ, Gonder-Frederick L, Ritterband L et al. Prediction of severe hypoglycemia. Diabetes Care 2007; 30: 1370–3.

18. Lalić NM, Lalić K, Jotić A, Stanojević D et al. The Impact of Structured Self-Monitoring of Blood Glucose Combined With Intensive Education on HbA1c Levels, Hospitalizations, and Quality-of-Life Parameters in Insulin-Treated Patients With Diabetes at Primary Care in Serbia: The Multicenter SPA-EDU Study. J Diabetes Sci Technol 2017; 11 (4): 746–52. DOI: 10.1177/1932296816681323

19. Machry RV, Rados DV, Gregório GR, Rodrigues TC. Self-monitoring blood glucose improves glycemic control in type 2 diabetes without intensive treatment: a systematic review and meta-analysis. Diabetes Res Clin Pract 2018; 142, 173–87.

20. Mannucci E, Antenore A, Giorgino F, Scavini M. Effects of structured versus unstructured self-monitoring of blood glucose on glucose control in patients with non-insulin-treated type 2 diabetes: A meta-analysis of randomized controlled trials. J Diabetes Sci Technol 2018; 12, 183–9.

21. Blonde L, Merilainen M, Karwe V, Raskin P, TITRATE™ Study Group. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets – the TITRATE™ study. Diabetes Obes Metab 2009; 11: 623–31.

22. Schnell O, Hanefeld M, Monnier L. Self-Monitoring of Blood Glucose A Prerequisite for Diabetes Management in Outcome Trials. J Diabetes Sci Technol 2014; 8 (3): 609–614. DOI: 10.1177/1932296814528134

23. Hon-Ke Sia, Chew-Teng Kor, Shih-Te Tu. Self-monitoring of blood glucose in association with glycemic control in newly diagnosed non-insulin-treated diabetes patients: a retrospective cohort study. Scientific Reports 2021; 11: 1176.  https://www.nature.com/articles/s41598-021-81024-x

24. Schnell O, Hanefeld M, Monnier L. Self-Monitoring of Blood Glucose A Prerequisite for Diabetes Management in Outcome Trials. J Diabetes Sci Technol 2014; 8 (3): 609–14. DOI: 10.1177/1932296814528134

25. McGeoch G, Derry S, Moore RA. Self-monitoringof blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab Res Rev 2007; 23: 423–40.

26. Martin S, Schneider B, Heinemann L et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006; 49: 271–8.

27. Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr Clin Res Rev 2020, 14, 303–10.

28. Fadini GP, Morieri ML, Longato E, Avogaro A. Prevalence and impact of diabetes among people infected with SARS-CoV-2.J. Endocrinol Investig 2020; 43: 867–9.

29. Глыбочко П.В., Фомин В.В., Авдеев С.Н. и др. Клиническая характеристика 1007 больных тяжелой SARS-CoV-2 пневмонией, нуждавшихся в респираторной поддержке. Клиническая фармакология и терапия. 2020; 29 (2): 21–9.

      [Glybochko P.V., Fomin V.V., Avdeev S.N. et al. Klinicheskaia kharakteristika 1007 bol'nykh tiazheloi SARS-CoV-2 pnevmoniei, nuzhdavshikhsia v respiratornoi podderzhke. Klinicheskaia farmakologiia i terapiia. 2020; 29 (2): 21–9 (in Russian).]

30. Banerjee M, Chakraborty S, Pal R. Diabetes self-management amid COVID-19 pandemic. Diabetes Metab Syndrome 2020. Clin Res Rev 2020; 14: 351–4.

31. Wang A, Zhao W, Xu Z, Gu J. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Res Clin Pract 2020: 162.

32. Bornstein SR, Rubino F, Khunti K et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol 2020. PII: S2213-8587(20)30152-2. DOI: 10.1016/S2213-8587(20)30152-2

33. Egi M. Acute glycemic control in diabetics. How sweet is optimal? Con: Just as sweet as in nondiabetic is better. J Intensive Care 2018;6:70. DOI: 10.1186/s40560-018-0337-1

34  McGeoch G, Derry S, Moore RA. Self-monitoringof blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab Res Rev 2007; 23: 423–40.

35. Schnell O, Alawi H, Battelino T et al. Addressing schemes of self-monitoring of blood glucose in type 2 diabetes: a European perspective and expert recommendation. Diabetes Technol Ther 2011; 13 (9): 959–65.

36. International Organization for Standardization. International Standard EN ISO 15197: 2013. In Vitro diagnostic test systems: Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Second Edition 2013-05-15. International Organization for Standardization, 2013.

37. Контур Плюс. Руководство пользователя. Байер, 2013.

      [Kontur Plius. Rukovodstvo pol'zovatelia. Baier, 2013 (in Russian).]

38. Bailey T. et al. Accuracy and User Performance Evaluation of a New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device. Journal of Diabetes Science and Technology. 2017; Vol. 11(4): 736-743.